Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 953, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.ejphar.2023.175862
Keywords
Depression; Fluoxetine; Vagus nerve; Restraint stress; Cefaclor
Categories
Ask authors/readers for more resources
This study investigated the effects of fluoxetine on anxiety and depression-like behaviors in mice with restraint stress or antibiotics-induced anxiety and depression. The results showed that fluoxetine alleviated these behaviors, but celiac vagotomy attenuated its anti-depressive effects.
The vagus nerve is a major pathway in the body that is responsible for regulating the activity of the para-sympathetic nervous system, which plays an important role in mood disorders including anxiety and depression. Fluoxetine, also known as Prozac, is widely used to treat depression. Nevertheless, there are few studies on the vagus nerve-mediated action of fluoxetine. In this study, we aimed to investigate the vagus nerve-dependent actions of fluoxetine in mice with restraint stress-induced or antibiotics-induced anxiety-and depression-like behaviors. Compared to sham operation, vagotomy alone did not exhibit significant effects on behavioral changes and serotonin-related biomarkers in mice not exposed to stress, antibiotics, or fluoxetine. Oral admin-istration of fluoxetine significantly alleviated anxiety-and depression-like behaviors. However, celiac vagotomy significantly attenuated the anti-depressive effects of fluoxetine. The vagotomy also inhibited the effect of fluoxetine to attenuate restraint stress-or cefaclor-induced reduction in serotonin levels and Htr1a mRNA expression in the hippocampus. These findings suggest that the vagus nerve may regulate the efficacy of fluoxetine for depression.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available